AR059221A1 - Compuestos piridinilaminoalquilen y piridiniloxialquilen-ciclopropanoaminas polisustituidas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen - Google Patents
Compuestos piridinilaminoalquilen y piridiniloxialquilen-ciclopropanoaminas polisustituidas, su procedimiento de preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR059221A1 AR059221A1 ARP070100362A ARP070100362A AR059221A1 AR 059221 A1 AR059221 A1 AR 059221A1 AR P070100362 A ARP070100362 A AR P070100362A AR P070100362 A ARP070100362 A AR P070100362A AR 059221 A1 AR059221 A1 AR 059221A1
- Authority
- AR
- Argentina
- Prior art keywords
- branched
- linear
- alkyl
- group
- groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Compuestos de formula (1) donde n representa un numero entero comprendido entre 1 y 6, ambos inclusive, X representa un átomo de oxígeno o un grupo NR6, Y representa un átomo de carbono o de nitrogeno, entendiéndose que cuando Y representa un átomo de nitrogeno no aparece Rd, Z representa un átomo de carbono o de nitrogeno, entendiéndose que cuando Z representa un átomo de nitrogeno no aparece Rc, R1 y R2, idénticos o diferentes, independientemente entre si, representan un átomo de hidrogeno o un grupo alquiloC1-6 lineal o ramificado o arilalquilo C1-6 lineal o ramificado, R3 y R4, idénticos o diferentes, independientemente entre sí, representan un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, R5 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, halogeno, hidroxilo, alcoxi C1-6 lineal o ramificado, ciano, nitro, acilo C2-6 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, trihaloalcoxi C1-6 lineal o ramificado, amino eventualmente sustituido con uno o dos grupos alquilo C1-6 lineales o ramificados, arilo o heteroarilo, R6 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado o arilalquilo C1-6 lineal o ramificado, Ra, Rb, Rc, Rd y Re, idénticos o diferentes, independientemente entre si, representan un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, halogeno, haloalquilo C1-6 lineal o ramificado, hidroxilo, alcoxi C1-6 lineal o ramificado, hidroxialquilo C1-6 lineal o ramificado, ciano, nitro, carboxi, isotiocianato, acilo C2-6 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, trihaloalcoxi C1-6 lineal o ramificado, alquiltio C1-6 lineal o ramificado, alquil C1-6)-carbonilamino siendo la parte alquilo lineal o ramificada, haloalquil C1-6-carbonilamino siendo la parte alquilo lineal o ramificada, aminocarbonilo, amino eventualmente sustituido con uno o dos grupos alquilo C1-6 lineales o ramificados, tetrazolilo, entendiéndose por grupo arilo un grupo fenilo, bifenilo, naftilo, dihidronaftilo, tetrahidronaftilo, indanilo e indenilo, estando cada uno de estos grupos eventualmente sustituidos con un o varios grupos, idénticos o diferentes, seleccionados de entre halogeno, alquilo C1-6 lineal o ramificado, hidroxilo, ciano, nitro, alcoxi C1-6 lineal o ramificado, acilo C2-7 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, trihaloalcoxi C1-6 lineal o ramificado y amino eventualmente sustituido con uno o dos grupos alquiio C1-6 lineales o ramificados, entendiéndose por grupo heteroarilo un sistema monocíclico aromático o bicíclico de 5 a 12 eslabones que contiene de uno a tres heteroátomos, idénticos o diferentes, seleccionados de entre oxígeno, nitrogeno y azufre, y en el cual uno de los ciclos, en caso de un sistema bicíclico, tiene carácter aromático, pudiendo el otro ciclo ser aromático o parcialmente hidrogenado, pudiendo cada uno de estos grupos estar eventualmente sustituidos con uno o varios grupos, idénticos o diferentes, seleccionados de entre los sustituyentes anteriormente definidos para el caso del grupo arilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0600784A FR2896800B1 (fr) | 2006-01-30 | 2006-01-30 | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059221A1 true AR059221A1 (es) | 2008-03-19 |
Family
ID=37102591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100362A AR059221A1 (es) | 2006-01-30 | 2007-01-29 | Compuestos piridinilaminoalquilen y piridiniloxialquilen-ciclopropanoaminas polisustituidas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20100317698A1 (es) |
| EP (1) | EP1979321B9 (es) |
| JP (1) | JP2009525311A (es) |
| KR (1) | KR101050910B1 (es) |
| CN (1) | CN101374814B (es) |
| AR (1) | AR059221A1 (es) |
| AT (1) | ATE437857T1 (es) |
| AU (1) | AU2007209235B2 (es) |
| BR (1) | BRPI0710443A2 (es) |
| CA (1) | CA2640482C (es) |
| CY (1) | CY1109477T1 (es) |
| DE (1) | DE602007001779D1 (es) |
| DK (1) | DK1979321T3 (es) |
| EA (1) | EA015227B1 (es) |
| ES (1) | ES2330899T3 (es) |
| FR (1) | FR2896800B1 (es) |
| GE (1) | GEP20105090B (es) |
| HK (1) | HK1126190A1 (es) |
| HR (1) | HRP20090523T1 (es) |
| MA (1) | MA30222B1 (es) |
| MY (1) | MY149068A (es) |
| NO (1) | NO20083753L (es) |
| PL (1) | PL1979321T3 (es) |
| PT (1) | PT1979321E (es) |
| RS (1) | RS51065B (es) |
| SI (1) | SI1979321T1 (es) |
| UA (1) | UA88116C2 (es) |
| WO (1) | WO2007085750A1 (es) |
| ZA (1) | ZA200806399B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102216289A (zh) * | 2008-10-14 | 2011-10-12 | 塞扣吉尼克斯公司 | 烟碱乙酰胆碱受体配体及其用途 |
| US8975261B2 (en) | 2011-05-24 | 2015-03-10 | Merck Sharp & Dohme Corp. | Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors |
| SG10202008486SA (en) | 2014-09-05 | 2020-09-29 | Celgene Quanticel Research Inc | Inhibitors of lysine specific demethylase-1 |
| US20180311238A1 (en) * | 2017-04-28 | 2018-11-01 | Saniona A/S | Selective Agonist Of a6 Containing nAChRs |
| CN110483392A (zh) * | 2018-05-14 | 2019-11-22 | 上海海和药物研究开发有限公司 | 合成n-保护的喹啉-7-基氧基甲基环丙基胺衍生物的方法及合成中间体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5326100A (en) * | 1999-06-07 | 2000-12-28 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| JP2001261652A (ja) * | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| FR2889188B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent |
| FR2889187B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2006
- 2006-01-30 FR FR0600784A patent/FR2896800B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-29 AR ARP070100362A patent/AR059221A1/es unknown
- 2007-01-30 DE DE602007001779T patent/DE602007001779D1/de active Active
- 2007-01-30 GE GEAP200710875A patent/GEP20105090B/en unknown
- 2007-01-30 CA CA2640482A patent/CA2640482C/fr not_active Expired - Fee Related
- 2007-01-30 EP EP07730888A patent/EP1979321B9/fr active Active
- 2007-01-30 UA UAA200810613A patent/UA88116C2/ru unknown
- 2007-01-30 AT AT07730888T patent/ATE437857T1/de active
- 2007-01-30 ZA ZA200806399A patent/ZA200806399B/xx unknown
- 2007-01-30 MY MYPI20082681A patent/MY149068A/en unknown
- 2007-01-30 PL PL07730888T patent/PL1979321T3/pl unknown
- 2007-01-30 EA EA200801681A patent/EA015227B1/ru not_active IP Right Cessation
- 2007-01-30 US US12/223,311 patent/US20100317698A1/en not_active Abandoned
- 2007-01-30 AU AU2007209235A patent/AU2007209235B2/en not_active Ceased
- 2007-01-30 WO PCT/FR2007/000170 patent/WO2007085750A1/fr active Application Filing
- 2007-01-30 JP JP2008552845A patent/JP2009525311A/ja not_active Withdrawn
- 2007-01-30 PT PT07730888T patent/PT1979321E/pt unknown
- 2007-01-30 ES ES07730888T patent/ES2330899T3/es active Active
- 2007-01-30 CN CN2007800039160A patent/CN101374814B/zh not_active Expired - Fee Related
- 2007-01-30 RS RSP-2009/0450A patent/RS51065B/sr unknown
- 2007-01-30 BR BRPI0710443-0A patent/BRPI0710443A2/pt not_active IP Right Cessation
- 2007-01-30 SI SI200730068T patent/SI1979321T1/sl unknown
- 2007-01-30 KR KR1020087021424A patent/KR101050910B1/ko not_active IP Right Cessation
- 2007-01-30 DK DK07730888T patent/DK1979321T3/da active
-
2008
- 2008-08-19 MA MA31181A patent/MA30222B1/fr unknown
- 2008-09-01 NO NO20083753A patent/NO20083753L/no not_active Application Discontinuation
-
2009
- 2009-05-11 HK HK09104298.2A patent/HK1126190A1/xx not_active IP Right Cessation
- 2009-09-29 HR HR20090523T patent/HRP20090523T1/hr unknown
- 2009-10-07 CY CY20091101033T patent/CY1109477T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
| AR069531A1 (es) | Derivados de indolinona y procedimiento para su fabricacion | |
| AR059221A1 (es) | Compuestos piridinilaminoalquilen y piridiniloxialquilen-ciclopropanoaminas polisustituidas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| AR061739A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CO5550472A2 (es) | Piperazinas heterociclicas sustituidas para el tratamiento de la esquizofrenia | |
| AR064730A1 (es) | Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk | |
| ECSP12011867A (es) | Derivados bencimidazol-imidazol | |
| AR060173A1 (es) | Derivados de piridina y de pirimidina como antagonistas del mglur2, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de trastornos del snc. | |
| CO6160235A2 (es) | Isoxazolinas insecticidas | |
| AR061642A1 (es) | Derivados de ureas de tropano, su preparacion y su aplicacion en terapeu-tica, procesos de obtencion y composiciones farmaceuticas | |
| AR091790A1 (es) | Derivados de isoquinolin-1-ona y sus usos | |
| DK1818057T3 (da) | Stabile farmaceutiske sammensætninger af montelukast-natrium | |
| AR044829A1 (es) | Derivados de bis-4-cloro fenil pirazinas | |
| AR059085A1 (es) | Derivados azufrados de urea ciclica su preparcion y su utilizacion farmaceutica como inhibidores de quinasas | |
| CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CO6270227A2 (es) | Derivados de quinazolinadiona su preparacion y sus aplicaciones terapeuticas | |
| CO6361956A2 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmaceúticas que los contienen | |
| ES2563320T3 (es) | Tintes azoicos dispersos | |
| PE20091426A1 (es) | Compuestos de piridina | |
| AR039601A1 (es) | Derivados de nitrosodifenilamina y composiciones farmaceuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologias que se caracterizan por estres oxidativo | |
| AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. | |
| CO6160310A2 (es) | Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7 | |
| CO6311082A2 (es) | Derivados de sulfonil-quinolina, procesos para su preparación y composiciones farmacéuticas que los contienen | |
| AR068372A1 (es) | Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen | |
| AR055770A1 (es) | Compuestos de piperazina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |